MIRA•benzinga•
EXCLUSIVE: MIRA Pharmaceuticals Tells Benzinga Co. Announces Results For Ketamir-2 In Diabetic Neuropathy Animal Model, Says Reinforcing Confidence Ahead Of Phase I Completion
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 16, 2025 by benzinga